Novo Nordisk

Sanofi can’t even buy a break now, as rival Novo speeds ahead on diabetes showdown
Endpoints
Mon, 08/22/16 - 11:41 am
Sanofi
Novo Nordisk
diabetes
Lantus
Xultophy
The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
GSK
Roche
Novo Nordisk
Tioma Therapeutics
CD47
immuno-oncology
Novo Nordisk sees pricing challenges "intensifying"
BioPharma Dive
Tue, 08/9/16 - 10:47 pm
Novo Nordisk
drug pricing
Novo's insulin pill shows promise in mid-stage trial
Yahoo/Reuters
Fri, 08/5/16 - 11:32 am
Novo Nordisk
clinical trials
diabetes
insulin
OI338GT
Novo’s Victoza Diabetes Medicine Rebuffed by Express Scripts
Bloomberg
Tue, 08/2/16 - 08:50 am
Novo Nordisk
Express Scripts
Victoza
PBMs
diabetes
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
diabetes
Novo Nordisk
Eli Lilly
GLP-1 agonist
Victoza
Trulicity
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Sat, 07/2/16 - 12:28 pm
Bayer
Abbott Labs
Novo Nordisk
Roche
Merck
Could Novo Nordisk’s 2016 Earnings Impress Wall Street?
Marketwatch
Tue, 06/28/16 - 11:06 am
Novo Nordisk
earnings
How Big Is the Diabetes Treatment Market?
Motley Fool
Wed, 06/22/16 - 07:06 pm
diabetes
Eli Lilly
Novo Nordisk
What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?
Motley Fool
Mon, 06/20/16 - 10:27 am
Novo Nordisk
diabetes
Victoza
Why This Pharma Giant Lost $8 Billion in Market Cap This Week
Fortune
Fri, 06/17/16 - 10:25 am
Novo Nordisk
Victoza
diabetes
Novo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street
Investors.com
Tue, 06/14/16 - 10:04 am
Novo Nordisk
diabetes
Victoza
Novo diabetes drug cuts heart risks by 13 pct in key trial
Yahoo/Reuters
Mon, 06/13/16 - 07:03 pm
Novo Nordisk
diabetes
Victoza
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Tue, 06/7/16 - 12:11 pm
public opinion
reputation
Bayer
Abbott Labs
Novo Nordisk
Roche
In unanimous vote, FDA panel recommends Novo diabetes drug
BioPharma Dive
Wed, 05/25/16 - 09:28 pm
FDA
advisory panels
Novo Nordisk
diabetes
IDegLira
Ahead of key panel vote, FDA staff raises concerns over Novo diabetes drug
BioPharma Dive
Mon, 05/23/16 - 10:40 am
FDA
advisory panels
Novo Nordisk
diabetes
IDegLira
FDA staffers air concerns over Novo's Victoza-Tresiba combo
Fierce Pharma
Sat, 05/21/16 - 12:40 pm
FDA
Novo Nordisk
diabetes
Xultophy
Tresiba
Victoza
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Seeking Alpha
Mon, 05/16/16 - 09:32 pm
Arena Pharmaceuticals
obesity
Orexigen
Belviq
Eisai
Vivus
Novo Nordisk
Qsymia
Victoza
Bayer, GSK, Novo and Roche rank in top 10 for online comms
Fierce Pharma
Wed, 05/11/16 - 10:40 am
communication
marketing
Bayer
GSK
Novo Nordisk
Roche
Novo Impressed Wall Street with Its 1Q16 Earnings
Yahoo/Market Realist
Mon, 05/2/16 - 10:03 pm
Novo Nordisk
earnings

Pages